Oncology Physicians: Discover What’s Next at Starling Oncology
Starling Oncology (NASDAQ: STLN) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Formerly known as The Oncology Institute, Starling Oncology offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With more than 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, Starling Oncology is changing oncology for the better. For more information, visit www.starlingoncology.com.
Oncology Physicians: Discover What’s Next at Starling Oncology
Starling Oncology is growing, and we’re looking for exceptional Hematology Oncology Physicians and Fellows who want to be part of what comes next.
Join us for our Virtual Physician Open House on September 16 and learn more about career opportunities across our expanding organization.
September 16
7:00 a.m. to 7:00 p.m. PT
100% Virtual
Drop in anytime. Come and go as your schedule permits.
You’ll hear directly from our CEO and Chief Medical Officer through exclusive video presentations about:
- Our exciting rebrand to Starling Oncology
• The continued growth and future of our organization
• Our approach to community based oncology care
• Opportunities for physicians to grow their careers with us
• What makes practicing at Starling Oncology different
Whether you’re actively considering your next opportunity, completing fellowship, or simply interested in learning more, this is an easy, no pressure way to meet Starling Oncology and explore what we’re building.
Your next chapter in Oncology could start here.
➡️ Register today and join us anytime on September 16Skills Required
- Hematology oncology physician or fellow
What We Do
Founded in 2007, The Oncology Institute of Hope and Innovation (NASDAQ: TOI) is a leader in value-based oncology, delivering highly specialized cancer care in the community setting. The company provides cutting-edge, evidence-based treatments to over 1.9 million patients through a network of more than 100 clinics. TOI integrates precision medicine, clinical trials, and compassionate support to improve long-term health outcomes and patient experiences.
